Acute coronary syndrome: biochemical strategies in the troponin era.
暂无分享,去创建一个
[1] A. Wu,et al. Quality Specifications for Cardiac Troponin Assays , 2001, Clinical chemistry and laboratory medicine.
[2] A. Wu,et al. Myocardial infarction redefined: role of cardiac troponin testing. , 2001, Clinical chemistry.
[3] A. Owen,et al. Troponin T: role in altering patient management and enabling earlier discharge from a district general hospital , 2001, Annals of clinical biochemistry.
[4] A. Wu,et al. International survey on the use of cardiac markers. , 2001, Clinical chemistry.
[5] J. Kao,et al. Comparison of Abbott AxSYM, Behring Opus Plus, DPC Immulite and Ortho-Clinical Diagnostics Vitros ECi for measurement of cardiac troponin I , 2001, Annals of clinical biochemistry.
[6] K. Thygesen,et al. Erratum: Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction (Journal of the American College of Cardiology (2000) 36 (959-969)) , 2001 .
[7] M. Panteghini. Recent approaches to the standardization of cardiac markers , 2001, Scandinavian journal of clinical and laboratory investigation.
[8] H. Katus,et al. Risk Stratification in Patients With Inferior Acute Myocardial Infarction Treated by Percutaneous Coronary Interventions: The Role of Admission Troponin T , 2000, Circulation.
[9] A. Siegbahn,et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. , 2000, The New England journal of medicine.
[10] S. Kaul,et al. Elevated Troponin I Level on Admission Is Associated With Adverse Outcome of Primary Angioplasty in Acute Myocardial Infarction , 2000, Circulation.
[11] S. Kahn. The challenge of evaluating the patient with chest pain. , 2000, Archives of pathology & laboratory medicine.
[12] P. Collinson,et al. Clinical evaluation of the first medical whole blood, point-of-care testing device for detection of myocardial infarction. , 2000, Clinical chemistry.
[13] T. Caragher,et al. Long-term experience with an accelerated protocol for diagnosis of chest pain. , 2000, Archives of pathology & laboratory medicine.
[14] A. Jaffe,et al. It's time for a change to a troponin standard. , 2000, Circulation.
[15] Hugo A. Katus,et al. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.
[16] U. Janssens,et al. Lower cardiac troponin T and I results in heparin-plasma than in serum. , 2000, Clinical chemistry.
[17] M. Plebani,et al. Rapid measurement of cardiac markers on Stratus CS. , 2000, Clinical chemistry.
[18] J P Ornato,et al. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. , 2000, JAMA.
[19] S. Blankenberg,et al. Analytical and Clinical Evaluation of Troponin I Determination on Dimension RXL-HM , 2000, Clinical chemistry and laboratory medicine.
[20] Robert Woolard,et al. Missed Diagnoses of Acute Cardiac Ischemia in the Emergency Department , 2000 .
[21] L. Goldman,et al. Evaluation of the patient with acute chest pain. , 2000, The New England journal of medicine.
[22] E. Antman,et al. Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a Thrombolysis In Myocardial Infarction (TIMI) 11B Substudy. , 2000, Clinical chemistry.
[23] J. Ravkilde. Risk stratification in acute coronary syndrome using cardiac troponin I. , 2000, Clinical chemistry.
[24] F. Apple,et al. Preliminary evaluation of the Vitros ECi cardiac troponin I assay. , 2000, Clinical chemistry.
[25] M. Panteghini. Present issues in the determination of troponins and other markers of cardiac damage. , 2000, Clinical biochemistry.
[26] R. Jesse,et al. Evaluation of the emergency department chest pain patient. , 2000, The American journal of cardiology.
[27] M. Panteghini,et al. Determination of Decision Limits for ACS:Systems Cardiac Troponin I , 2000, Clinical chemistry and laboratory medicine.
[28] R. Califf,et al. Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries. , 1999, The American journal of cardiology.
[29] I. Menown,et al. Optimizing classification of acute myocardial infarction: from diagnosis to prognosis. , 1999, European heart journal.
[30] J. Soler‐Soler,et al. QT dispersion after myocardial infarction with heart failure: additional prognostic marker? , 1999, European heart journal.
[31] A. Remppis,et al. Quantitative bedside assay for cardiac troponin T: a complementary method to centralized laboratory testing. , 1999, Clinical chemistry.
[32] W. Gibler,et al. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. , 1999, Clinical chemistry.
[33] A. Jaffe,et al. 2001--a biomarker odyssey. , 1999, Clinica chimica acta; international journal of clinical chemistry.
[34] F. Dati,et al. Use of Biochemical Markers in Acute Coronary Syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage , 1999, Clinical chemistry and laboratory medicine.
[35] M. Panteghini. Biochemical assessment of myocardial damage with new diagnostic tools. , 1999, Cardiologia.
[36] M Zaninotto,et al. Strategies for the early diagnosis of acute myocardial infarction using biochemical markers. , 1999, American journal of clinical pathology.
[37] D. Fink,et al. Multicenter clinical and analytical evaluation of the AxSYM troponin-I immunoassay to assist in the diagnosis of myocardial infarction. , 1999, Clinical chemistry.
[38] R. Jesse. Myocardial necrosis in "pure unstable angina": identification of high-risk subgroups or a contradiction in terms? , 1999, American heart journal.
[39] M. Panteghini,et al. The Sensitivity of Cardiac Markers: an Evidence-based Approach , 1999, Clinical chemistry and laboratory medicine.
[40] A. Wu,et al. Biochemical differences between cTnT and cTnI and their significance for diagnosis of acute coronary syndromes. , 1998, European heart journal.
[41] M. Panteghini,et al. Diagnostic application of CK-MB mass determination. , 1998, Clinica chimica acta; international journal of clinical chemistry.
[42] F. Apple,et al. Cardiac troponin T composition in normal and regenerating human skeletal muscle. , 1997, Clinical chemistry.
[43] D Wybenga,et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. , 1996, The New England journal of medicine.
[44] F. Harrell,et al. Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia , 1996 .
[45] M. Noble,et al. Prognostic significance of admission troponin T concentrations in patients with myocardial infarction. , 1996, Circulation.
[46] L. Wallentin,et al. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. , 1996, Circulation.
[47] E. Cook,et al. Clinical characteristics and outcome of acute myocardial infarction in patients with initially normal or nonspecific electrocardiograms (a report from the Multicenter Chest Pain Study). , 1989, The American journal of cardiology.
[48] H E Solberg,et al. Approved recommendation (1988) on the theory of reference values. Part 3. Preparation of individuals and collection of specimens for the production of reference values. , 1988, Clinica chimica acta; international journal of clinical chemistry.
[49] C. Petitclerc,et al. Approved recommendation (1987) on the theory of reference values. Part 2. Selection of individuals for the production of reference values , 1987 .
[50] H. E. Solberg. Approved recommendation (1987) on the theory of reference values. Part 5. Statistical treatment of collected reference values. Determination of reference limits , 1987 .
[51] G W Rouan,et al. Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room. , 1987, The American journal of cardiology.
[52] H E Solberg,et al. The theory of reference values Part 5. Statistical treatment of collected reference values. Determination of reference limits. , 1983, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.
[53] A. Wu,et al. Validation of NACB and IFCC guidelines for the use of cardiac markers for early diagnosis and risk assessment in patients with acute coronary syndromes. , 2001, Clinica chimica acta; international journal of clinical chemistry.
[54] R. Christenson,et al. Evidence based approach to practice guides and decision thresholds for cardiac markers. , 1999, Scandinavian journal of clinical and laboratory investigation. Supplementum.
[55] F. Apple. Biochemical markers of thrombolytic success , 1999 .
[56] K. Hallermayer,et al. Use of recombinant human cardiac Troponin T for standardization of third generation Troponin T methods. , 1999, Scandinavian journal of clinical and laboratory investigation. Supplementum.
[57] F. Apple,et al. Clinical and analytical standardization issues confronting cardiac troponin I. , 1999, Clinical chemistry.
[58] B. Lindahl. Therapeutic implications of the use of cardiac markers in acute coronary syndromes. , 1999, Scandinavian journal of clinical and laboratory investigation. Supplementum.
[59] F. Apple. Biochemical markers of thrombolytic success. IFCC Committee on Standardization of Markers of Cardiac Damage. , 1999, Scandinavian journal of clinical and laboratory investigation. Supplementum.